JP2015516950A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015516950A5 JP2015516950A5 JP2015502460A JP2015502460A JP2015516950A5 JP 2015516950 A5 JP2015516950 A5 JP 2015516950A5 JP 2015502460 A JP2015502460 A JP 2015502460A JP 2015502460 A JP2015502460 A JP 2015502460A JP 2015516950 A5 JP2015516950 A5 JP 2015516950A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmacologically active
- pharmaceutical composition
- active material
- acoustic
- additive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1205632.1A GB201205632D0 (en) | 2012-03-30 | 2012-03-30 | Method and apparatus |
| GB1205632.1 | 2012-03-30 | ||
| PCT/GB2013/050847 WO2013144655A1 (en) | 2012-03-30 | 2013-03-28 | Method and apparatus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015516950A JP2015516950A (ja) | 2015-06-18 |
| JP2015516950A5 true JP2015516950A5 (enExample) | 2016-05-26 |
Family
ID=46159980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015502460A Pending JP2015516950A (ja) | 2012-03-30 | 2013-03-28 | 方法と装置 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20150059746A1 (enExample) |
| EP (1) | EP2830751A1 (enExample) |
| JP (1) | JP2015516950A (enExample) |
| KR (1) | KR20140142264A (enExample) |
| CN (1) | CN104203385A (enExample) |
| AU (1) | AU2013239409A1 (enExample) |
| CA (1) | CA2867097A1 (enExample) |
| GB (1) | GB201205632D0 (enExample) |
| HK (1) | HK1206670A1 (enExample) |
| IL (1) | IL234659A0 (enExample) |
| IN (1) | IN2014DN08753A (enExample) |
| MX (1) | MX2014011795A (enExample) |
| NZ (1) | NZ629920A (enExample) |
| RU (1) | RU2014143807A (enExample) |
| SG (2) | SG10201608088YA (enExample) |
| WO (1) | WO2013144655A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9107851B2 (en) | 2012-10-15 | 2015-08-18 | New Jersey Institute Of Technology | Solventless mixing process for coating pharmaceutical ingredients |
| AU2013345062B2 (en) * | 2012-11-16 | 2018-02-08 | Merck Sharp & Dohme Corp. | Process for making agglomerates using acoustic mixing technology |
| US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| CN105473133A (zh) | 2013-04-30 | 2016-04-06 | 欧缇托匹克公司 | 干粉制剂及使用方法 |
| WO2015049519A2 (en) * | 2013-10-02 | 2015-04-09 | Vectura Limited | Method and apparatus |
| GB201321712D0 (en) * | 2013-12-09 | 2014-01-22 | Pharmachemie Bv | Dry Powder Inhaler |
| WO2015094927A1 (en) * | 2013-12-17 | 2015-06-25 | Merck Sharp & Dohme Corp. | Media milling process for the manufacture of active pharmaceutical ingredients in propellants |
| TR201818680T4 (tr) * | 2014-07-09 | 2019-01-21 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | İnhalasyona yönelik formülasyonların hazırlanması için bir proses. |
| HRP20260435T1 (hr) | 2014-09-09 | 2026-05-08 | Vectura Limited | Formulacija koja sadrži glikopirolat, postupak i uređaj |
| AU2016241369A1 (en) * | 2015-04-01 | 2017-11-02 | Lupin Atlantis Holdings Sa | Process for manufacturing dry powder blends |
| US9968223B2 (en) | 2015-06-12 | 2018-05-15 | Sunbeam Products, Inc. | Blending appliance with paddle blade |
| WO2017007895A1 (en) * | 2015-07-07 | 2017-01-12 | Abbvie Inc. | Acoustic mixing for auto granulation |
| WO2017047650A1 (ja) * | 2015-09-14 | 2017-03-23 | 大和製罐株式会社 | 粉末吸入剤、吸入器、及び粉末吸入剤の製造方法 |
| CA3076353A1 (en) | 2017-09-22 | 2019-03-28 | Otitopic Inc. | Dry powder compositions with magnesium stearate |
| US10786456B2 (en) | 2017-09-22 | 2020-09-29 | Otitopic Inc. | Inhaled aspirin and magnesium to treat inflammation |
| CN112752572B (zh) * | 2019-05-23 | 2022-02-22 | 广州谷森制药有限公司 | 含有三苯乙酸维兰特罗和芜地溴铵的可吸入溶液组合物 |
| CN111297837B (zh) * | 2020-03-26 | 2022-02-22 | 上海方予健康医药科技有限公司 | 一种干粉吸入剂的制备方法 |
| CN113144997B (zh) * | 2021-03-23 | 2022-10-25 | 西安近代化学研究所 | 共振声混合中临界波动率确定、混合均匀性判定方法及系统 |
| KR102796431B1 (ko) * | 2021-09-17 | 2025-04-16 | 주식회사 케이티앤지 | 흡연 물품 및 에어로졸 발생 시스템 |
| US12157098B2 (en) * | 2021-12-14 | 2024-12-03 | Honeywell Federal Manufacturing & Technologies, Llc | Resonant acoustic mixing system and method |
| WO2023196663A1 (en) * | 2022-04-07 | 2023-10-12 | Board Of Regents, The University Of Texas System | Methods of preparing carrier-based dry powders for inhalation |
| JP2025523707A (ja) * | 2022-05-28 | 2025-07-23 | アヴァリン ファーマ インク． | ニンテダニブおよびニンテダニブの組み合わせ乾燥粉末組成物と使用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4990696A (en) * | 1995-02-24 | 1996-09-11 | Nanosystems L.L.C. | Aerosols containing nanoparticle dispersions |
| US20070212422A1 (en) * | 1999-11-10 | 2007-09-13 | Manfred Keller | Dry powder for inhalation |
| JP2004533917A (ja) * | 2001-05-01 | 2004-11-11 | グラクソ グループ リミテッド | 解塊装置および方法 |
| GB0205327D0 (en) * | 2002-03-06 | 2002-04-17 | Glaxo Group Ltd | compounds |
| AU2003263024A1 (en) * | 2002-04-23 | 2003-11-10 | Christopher Mcconville | Process of forming and modifying particles and compositions produced thereby |
| US7188993B1 (en) * | 2003-01-27 | 2007-03-13 | Harold W Howe | Apparatus and method for resonant-vibratory mixing |
| US20060152998A1 (en) * | 2003-09-10 | 2006-07-13 | Burr Ronald F | Acoustic fluidized bed |
| GB0321607D0 (en) * | 2003-09-15 | 2003-10-15 | Vectura Ltd | Manufacture of pharmaceutical compositions |
| GB0605676D0 (en) * | 2006-03-22 | 2006-05-03 | Vectura Ltd | Improvements in extraction of powder formulations |
| EP2082767A1 (en) * | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
| US9956170B2 (en) * | 2008-06-26 | 2018-05-01 | 3M Innovative Properties Company | Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof |
| WO2010007447A1 (en) * | 2008-07-18 | 2010-01-21 | Prosonix Limited | Process for improving crystallinity |
| RU2580312C2 (ru) * | 2010-04-21 | 2016-04-10 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Способ получения частиц с пониженным электростатическим зарядом |
| JP5830702B2 (ja) | 2010-04-28 | 2015-12-09 | パナソニックＩｐマネジメント株式会社 | 回路装置の製造方法 |
| KR20140147891A (ko) * | 2012-04-13 | 2014-12-30 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | 응집체 입자 |
| AU2013345062B2 (en) * | 2012-11-16 | 2018-02-08 | Merck Sharp & Dohme Corp. | Process for making agglomerates using acoustic mixing technology |
-
2012
- 2012-03-30 GB GBGB1205632.1A patent/GB201205632D0/en not_active Ceased
-
2013
- 2013-03-28 KR KR1020147027247A patent/KR20140142264A/ko not_active Withdrawn
- 2013-03-28 SG SG10201608088YA patent/SG10201608088YA/en unknown
- 2013-03-28 SG SG11201405555RA patent/SG11201405555RA/en unknown
- 2013-03-28 HK HK15107349.6A patent/HK1206670A1/xx unknown
- 2013-03-28 EP EP13715413.4A patent/EP2830751A1/en not_active Withdrawn
- 2013-03-28 US US14/387,629 patent/US20150059746A1/en not_active Abandoned
- 2013-03-28 CA CA2867097A patent/CA2867097A1/en not_active Abandoned
- 2013-03-28 NZ NZ629920A patent/NZ629920A/en not_active IP Right Cessation
- 2013-03-28 WO PCT/GB2013/050847 patent/WO2013144655A1/en not_active Ceased
- 2013-03-28 AU AU2013239409A patent/AU2013239409A1/en not_active Abandoned
- 2013-03-28 CN CN201380016626.5A patent/CN104203385A/zh active Pending
- 2013-03-28 JP JP2015502460A patent/JP2015516950A/ja active Pending
- 2013-03-28 RU RU2014143807A patent/RU2014143807A/ru not_active Application Discontinuation
- 2013-03-28 MX MX2014011795A patent/MX2014011795A/es unknown
-
2014
- 2014-09-15 IL IL234659A patent/IL234659A0/en unknown
- 2014-10-17 IN IN8753DEN2014 patent/IN2014DN08753A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7462645B2 (en) | Bronchodilating beta-agonist compositions and methods | |
| NZ629920A (en) | A method for making an inhalable pharmaceutical composition using a resonant acoustic blender | |
| JP2020079295A (ja) | ロフルミラストｎ−酸化物の吸入によって自己免疫、呼吸器性および炎症性の障害を処置する方法 | |
| IL143986A (en) | Combinations of formotrol and tiotropium salt | |
| JP2015519356A5 (enExample) | ||
| JP2013542940A5 (enExample) | ||
| AR075516A1 (es) | Composicion farmaceutica para inhalacion | |
| NZ627837A (en) | Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation | |
| JP2013531056A5 (enExample) | ||
| EP2682108A3 (en) | Dry Powder Inhalers Comprising a Carrier Other Than Lactose and a Ternary Component | |
| JP2017039746A (ja) | 医薬組成物 | |
| JP2019528316A5 (enExample) | ||
| EP2682097A3 (en) | Dry Powder Inhalers Comprising A Carrier Other Than Lactose | |
| MX2018014425A (es) | Beta-horquilla peptidomimetica con actividad inhibidora de elastasa y formas de dosificacion en aerosol de la misma. | |
| WO2015116856A3 (en) | Farnesoid x receptor antagonists | |
| JOP20200314A1 (ar) | تركيبات صيدلانية مستقرة لأجهزة إستنشاق جرعات مضغوطة معايرة الجرعة | |
| WO2015049519A3 (en) | Method and apparatus for making compositions for pulmonary administration | |
| WO2016071862A1 (en) | Inhalable pharmaceutical composition comprising glycopyrronium | |
| EP4616915A3 (en) | Ecopipam for treatment of tourettes syndrome | |
| KR20180101438A (ko) | 7-아조니아바이사이클로[2.2.1]헵탄 유도체의 건조 분말 흡입기 조성물 | |
| WO2017077488A1 (en) | An inhalable fixed dose powder composition comprising glycopyrronium and formoterol | |
| Chapman et al. | Pharmacology of SCH900182, a potent, selective inhibitor of PDE4 for inhaled administration | |
| Siler et al. | Tolerability of Revefenacin and Formoterol Via Nebulization in Patients With Moderate to Very Severe COPD: A Subgroup Analysis of a Phase 3 Trial | |
| MX372705B (es) | Composición farmacéutica que contiene budesonida y formoterol | |
| Ferguson et al. | Roflumilast Treatment in COPD Patients Taking a Fixed-Dose Combination of Long-Acting ²2 Agonist (LABA) and Inhaled Corticosteroid (ICS): Rationale and Design of a Prospective Randomized Controlled Trial |